EJCTS Click here for details of sales representative
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wilhelmi, M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Wilhelmi, M.
Related Collections
Right arrow Coronary disease

Eur J Cardiothorac Surg 2002;21:161
© 2002 Elsevier Science NL

Letter to the Editor

Reply to Casati

Michaela Wilhelmi*

Department of Thoracic and Cardiovascular Surgery, Hannover Medical School, Carl-Neuberg-Strasse 1, D-30623 Hannover, Germany

Received 15 October 2001; accepted 16 October 2001.

* Tel.: +49-511-532-6580; fax: +49-511-532-6581
e-mail: wilhelmi{at}thg.mh-hannover.de

Thank you very much for you letter concerning our manuscript, which we have previously published in the European Journal of Cardio-thoracic Surgery [1].

We strongly appreciate your great interest in and your extraordinary knowledge on the topic.

We deeply apologize for the delay of our reply, but thought that these questions had been addressed by our previously published reply to Dr Belcher and Dr Muriithi [2].

Again, we absolutely agree with you that prophylactic transfusion of blood products in CABG patients is obsolete and should definitely not be performed in these patients, which is underlined by our data. However, we agree that the final sentence of our paper may indeed cause some understanding problems. The meaning of the sentence is that we suggest that "This approach (NOT to use blood products in CABG patients!) should be considered for routine use in patients undergoing CABG without previous thoracic surgical interventions or coagulation disorders".

We hope this will clarify the issue now and take the opportunity to thank you once again for your special interest in our work.

References

  1. Wilhelmi M., Franke U., Cohnert T., Weber P., Kaukemüller J., Fischer S., Wahlers T., Haverich A. Coronary artery bypass grafting surgery without the routine application of blood products: is it feasible?. Eur J Cardiothorac Surg 2001;19:657-661.[Abstract/Free Full Text]
  2. Wilhelmi M. Reply to Belcher and Muriithi. Eur J Cardiothorac Surg 2001;20:1079.[Free Full Text]




This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wilhelmi, M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Wilhelmi, M.
Related Collections
Right arrow Coronary disease

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS